Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Other Gross PP&E Adjustments: 2010-2025

Historic Other Gross PP&E Adjustments for China Pharma Holdings (CPHI) over the last 15 years, with Sep 2025 value amounting to $37.3 million.

  • China Pharma Holdings' Other Gross PP&E Adjustments fell 1.54% to $37.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $148.5 million, marking a year-over-year decrease of 0.87%. This contributed to the annual value of $36.9 million for FY2024, which is 1.16% down from last year.
  • China Pharma Holdings' Other Gross PP&E Adjustments amounted to $37.3 million in Q3 2025, which was up 0.22% from $37.2 million recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Other Gross PP&E Adjustments registered a high of $37.9 million during Q3 2024, and its lowest value of -$25,369 during Q1 2021.
  • Its 3-year average for Other Gross PP&E Adjustments is $30.6 million, with a median of $37.2 million in 2025.
  • Per our database at Business Quant, China Pharma Holdings' Other Gross PP&E Adjustments plummeted by 105.37% in 2021 and then soared by 6,978.34% in 2024.
  • Quarterly analysis of 5 years shows China Pharma Holdings' Other Gross PP&E Adjustments stood at $488,309 in 2021, then soared by 5,733.46% to $28.5 million in 2022, then skyrocketed by 31.21% to $37.4 million in 2023, then fell by 1.16% to $36.9 million in 2024, then dropped by 1.54% to $37.3 million in 2025.
  • Its Other Gross PP&E Adjustments was $37.3 million in Q3 2025, compared to $37.2 million in Q2 2025 and $37.1 million in Q1 2025.